Lifetime cardiovascular management of patients with previous Kawasaki Disease
Increasing numbers of patients who suffered Kawasaki Disease in childhood are transitioning to the care of adult services where there is significantly less awareness and experience of the condition than in paediatric services. The aim of this document is to provide guidance on the long-term management of patients who have vascular complications of Kawasaki Disease […]
Kawasaki Disease: a prospective population survey in the UK and Ireland from 2013 to 2015
Kawasaki Disease is an increasingly common vasculitis with risk of coronary artery aneurysms. The last UK survey was in 1990. Current epidemiology, treatment patterns and complication rates are unknown. The aim of this study, undertaken across the UK and Ireland, was to address this knowledge gap.
Utility of Coronary Computed Tomography Angiography in the Diagnosis and Management of Acute-Phase Adult-Onset Kawasaki Disease
A Japanese paper describing the use of CCTA to support Kawasaki Disease diagnosis.
Failure to Predict High-Risk Kawasaki Disease Patients in a Population-Based Study Cohort in Germany. – PubMed – NCBI
This paper looks at scoring methods to predict responses to IVIG therapy in a Caucasian population
Retrospective study of the impact of unrecognised Kawasaki Disease, coronary aneurysm and ectasia
The first UK study to retrospectively review and characterise the angiographic prevalence of Kawasaki Disease
Management of Kawasaki Disease in adults
This review addresses gaps in the current knowledge of the disease and its optimal treatment, differences in the AHA and JCS guidelines, targets for future research and obstacles to transition of care from adolescence into adulthood.
Dissecting Kawasaki disease: a state-of-the-art review
A discussion paper on Kawasaki Disease which concludes that many aspects of KD remain unknown, although there is growing knowledge on the etiology
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart
AHA 2017 recommendations provide updated and best evidence-based guidance to healthcare providers who diagnose and manage Kawasaki disease, but clinical decision making should be individualized to specific patient circumstances.
NIHR Signal Corticosteroids given early reduce risk of heart problems in children with Kawasaki disease
This study suggests that early treatment with corticosteroids on top of standard therapy reduces the risk of serious heart problems in children under five with Kawasaki Disease.
Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention
This systematic review and meta-analysis demonstrates that adjunctive corticosteroid therapy was associated with a significantly lower rate of coronary artery complication compared with intravenous immunoglobulin therapy, particularly among high-risk patients.